MENSCHLICHE VORLÄUFERZELLEN

European patent · EP2352816 · In force

Register entry

Publication number
EP2352816
Application number
EP09824313
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 6, 2009
Published
Aug 10, 2011
Granted
Jun 24, 2015
Protection ends at the latest
Nov 5, 2029
Next annual fee due
Nov 30, 2026
IPC classes
A61K 35/12 (2015.01)
C12N 5/0789 (2010.01)
C12N 5/0775 (2010.01)
C12N 5/077 (2010.01)
G01N 33/50 (2006.01)
C12N 5/0783 (2010.01)
Priority
US 112503 P 07.11.2008
PCT application
PCT/CA2009/001601 06.11.2009
PCT publication
WO2010/051634 14.05.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  5. Jun 24, 2015

    Granted

    Published in Swissreg on 24.06.2015

Parties

Holder

Sunnybrook Health Sciences Centre

2075 Bayview Avenue Room S-130, Toronto, Ontario M4N 3M5, CA

Inventor

ZUNIGA-PFLÜCKER, Juan, Carlos

Toronto Ontario M6G 3L9, CA

AWONG, Geneve

Toronto Ontario M4Y 2P8, CA

LA MOTTE-MOHS, Ross

Germantown, MD 20874, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.